-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence: Poster III

Symposia: Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Hanadi Rafii, MD1*, Regis Peffault De Latour2*, Marc Bierings, MD3, Jean-Hugues Dalle4*, Mouhab F. Ayas, MD5*, Rawad Rihani, MD, MSc6*, Edoardo Lanino, MD7*, Chantal Kenzey, RA1*, Fernanda Volt, MSc1*, Monica M. M Rivera Franco, MD, PhD1*, Barbara Cappelli, MD8,9*, Graziana Scigliuolo, PharmD8,9*, Vanderson Rocha, MD, PhD, MS1,10*, Annalisa Ruggeri, MD, PhD1,11*, Antonio M Risitano, MD, PhD12,13 and Éliane Gluckman, MD, PhD1,8

1Eurocord, Hôpital Saint Louis APHP, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France
2Hôpital Saint-Louis,, Paris, France
3Princess Máxima Center, University Hospital for Children, Utrecht, Netherlands
4Pediatric hematology and immunology department, Robert-Debré Hospital, GHU APHP Nord Université Paris-Cité, Paris, France
5Department of Pediatric Hematology and BMT, King Faisal Specialist Hospital & Research Center, Riyadh, Middle, SAU
6Pediatric Blood and Marrow and Cellular Therapy Program, King Hussein Cancer Center, Amman, Jordan
7Istituto Giannina Gaslini, Genova, ITA
8Monacord, Centre Scientifique De Monaco, Monaco, Monaco
9Eurocord, Institut de Recherche de Saint-Louis (IRSL) EA3518, Université de Paris Cité, Paris, France
10Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas, Faculty of Medicine, São Paulo University, São Paulo, Brazil., São Paulo, Brazil
11Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy
12University of Naples, Avellino, Italy
13A.O.R.N. San Giuseppe Moscati, Avellino, Italy

Ayman Sayyed, BMBS, MRCP1*, Taehyung Simon Kim2*, Silvia Park3*, Jae-Sook Ahn4*, Aly Karsan, MD5, Marie-France Gagnon, MD6*, Julie Bergeron, MD6, Hyeoung-Joon Kim4, Heeje Kim, MD, PhD7, David Sanford, MD, FRCPC8, Andre C. Schuh, MD, FRCPC2 and Dennis Dong Hwan Kim, MD, PhD2

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Riyadh, Saudi Arabia
2Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
4Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
5BC Cancer Research Institute, University of British Columbia, Vancouver, BC, CAN
6CEMTL, installation Maisonneuve-Rosemont, Montreal, QC, Canada
7Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
8Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Vancouver, Canada

Andrius Žučenka, MD1, Ghayas C. Issa2, Martha Arellano3, Sajad Khazal2, Nandita Khera, MD4, Wendy Stock, MD5, Branko Cuglievan2, Yu Gu6*, Huy Van Nguyen6*, Angela R. Smith7* and Eytan M. Stein8

1Hematology and Oncology Department, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Emory University School of Medicine, Atlanta, GA
4Mayo Clinic, Phoenix, AZ
5University of Chicago Medicine, Chicago, IL
6Syndax Pharmaceuticals, Inc., Waltham, MA
7Syndax Pharmaceuticals, Inc, Waltham, MA
8Memorial Sloan Kettering Cancer Center, New York, NY

Jianying Zhou1*, Song Wang2,3,4,5*, Ting Niu, MD, PhD6,7, Ming Jiang8*, Shunqing Wang, M.D., Ph.D.9*, Wen Wang10*, Xi Zhang, PhD11, Yujun Dong12*, Dingming Wan13*, Xin Du, PhD14*, Xudong Wei15*, Han Zhu16*, Yuhua Li17*, Kehong Bi18*, Xianmin Song, phd19, Yi Chen20*, Li Liu21*, Yi Luo22*, Yuhong Zhou23*, Xin Li, MD24*, Yajing Xu, MD25*, Yicheng Zhang26*, Xiaoliang Liu27*, Hai Yi28*, Xiaobing Huang29*, Zunmin Zhu, MD, PhD30*, Jianmin Yang31*, Fang Zhou32* and Xiaohui Zhang1*

1Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
2Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China;, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China, Beijing, China
4National Clinical Research Center for Hematologic Disease, Beijing, China;, Beijing, China
5Collaborative Innovation Center of Hematology, Peking University, Beijing, China, Beijing, China
6Department of Hematology, West China Hospital, Sichuan University, Chengdu, CHN
7West China Hospital Sichuan University, Chengdu, Sichuan, China
8Department of Hematology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
9Department of Hematology, Guangzhou First People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou, China
10Department of Hematology, Qilu Hospital, Shandong University, Jinan, China
11Army medical University affiliated Xinqiao Hospital, Chongqing, China
12Department of Hematology, Peking University First Hospital, Beijing, CHN
13Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
14Guangdong Provincial People’s Hospital, Guangzhou, WA, CHN
15Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
16Department of Hematology, Jiangsu Province Hospital, the First Affiliated Hospital With Nanjing Medical University, Nanjing, CHN
17Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
18Department of Hematology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China
19Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
20Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
21Department of Hematology, the Second Affiliated Hospital (Tangdu Hospital) of Air Force Medical University, Xi'an, China
22Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
23Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China
24The Third Xiangya Hospital of Central South University, Changsha, China
25Department of Hematoogy, Xiangya Hospital, Central South University, Changsha, China
26Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
27Department of Hematology, Cancer Center, the First Hospital of Jilin University, Changchun, China
28Department of Hematology, Western Theater General Hospital of the People's Liberation Army of China, Chengdu, China
29Department of Hematology, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
30Department of Hematology, Henan Provincial People’s Hospital, Zhengzhou, China
31Department of Hematology, Changhai Hospital, The Naval Medical University, Shanghai, China
32Department of Hematology, the 960th Hospital of the People's Liberation Army of China, Jinan, China

Yigeng Cao1*, Wenwen Guo2*, Weihua Zhai1*, Jialin Wei1*, Qiaoling MA1*, Donglin Yang1*, AiMing Pang2*, Mingzhe Han2* and Erlie Jiang, PhD1

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Jianyun Liao1*, Chaoke Bu1*, Lan He1*, Yuelin He1*, Jujian He1*, Dan Chen1*, Bo Lyu1*, Weiwei Zhang1*, Haoran Tang1*, Xinrui Liu1* and Chunfu Li, PhD2

1Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, China
2Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, Guangdong, China

Ayman Sayyed, BMBS, MRCP1*, Taehyung Simon Kim2*, Silvia Park3*, Jae-Sook Ahn4*, Aly Karsan, MD5, Marie-France Gagnon, MD6*, Julie Bergeron, MD6, Hee-Je Kim7*, Hyeoung-Joon Kim4, David Sanford, MD, FRCPC8, Andre C. Schuh, MD, FRCPC2 and Dennis Dong Hwan Kim, MD, PhD2

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Riyadh, Saudi Arabia
2Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
4Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
5BC Cancer Research Institute, University of British Columbia, Vancouver, BC, CAN
6CEMTL, installation Maisonneuve-Rosemont, Montreal, QC, Canada
7Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Seoul, Korea, Republic of (South)
8Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Vancouver, Canada

Elizabeth Stenger, MD, MSc1, Tami D. John, MD2*, Deepak Chellapandian, MD3, Rikin Shah, MD4*, Scott Gillespie5*, Yijin Xiang5*, Katie Liu5*, Monica Bhatia, MD6*, Gregory M.T. Guilcher, MD7, Jennifer Jaroscak, MD8, Kimberly A. Kasow, DO9*, Jennifer Krajewski, MD10*, Alexander I. Ngwube, MD11*, Hemalatha G. Rangarajan, MD12, John T. Horan, MD13, Lakshmanan Krishnamurti, MD14, Shalini Shenoy, MD, MBBS15 and Allistair Abraham, MD16

1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA
2Lucile Packard Children's Hospital, Stanford University, Los Altos, CA
3John's Hopkin's Medical Institution, St Petersburg, FL
4Arnold Palmer Hospital, Orlando, FL
5Emory University, Atlanta, GA
6Division of Hematology, Oncology, and Stem Cell Transplant, Morgan Stanley Children’s Hospital, Columbia University, New York, NY, USA, New York, NY
7Department of Pediatrics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Alberta Children’s Hospital, Calgary, AB, Canada
8Medical University of South Carolina, Charleston, SC
9University of North Carolina, Chapel Hill, NC
10Hackensack University Medical Center, Hackensack, NJ
11Phoenix Children's Hospital, Phoenix, AZ
12Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Childrens Hospital, Columbus, OH
13Harvard University, Dana Farber Cancer Institute, Boston, MA
14Section of Pediatric Hematology, Oncology and Bone Marrow Transplant, Yale School of Medicine, Atlanta, GA
15Washington University Medical Center, Saint Louis, MO
16Children's National Medical Center, Washington, DC

Katherine Tarlock, MD1,2, Emily C Merkel, MD1,2, Todd Cooper, DO1, Corinne Summers, MD1,2*, Monica Thakar, MD1,2, Paul A Carpenter, MD1,2, Aleksandra Petrovic, MD1,2*, Ross Goshorn, MD3*, Robert Irwin, MD4*, Ted Gooley, PhD2*, Marie Bleakley, PhD, MBBS, MMSc5,6 and Ann Dahlberg, MD1,2*

1Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Providence Sacred Heart Medical Center, Spokane, WA
4Mary Bridge Children's Hospital, Tacoma, WA
5Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
6Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital and University of Washington, Seattle, WA

Patrice Chevallier, MD1, Anne Thiebaut, MD2*, Sylvie François, MD3*, Sylvain Chantepie, MD4*, Marie Thérèse Rubio, MD, PhD5*, Hélène Labussière-Wallet6*, Eolia Brissot7*, Natacha Maillard, MD8*, Anne Huynh, MD9*, Valerie Coiteux, MD10*, Alice Garnier, MD11*, Amandine Le Bourgeois12*, Pierre Peterlin1* and Thierry Guillaume, MD, PhD12*

1Nantes University Hospital, Nantes, France
2service d'hématologie clinique, CHUGA Grenoble, Grenoble, France
3Maladies du sang, CHU Angers, Angers, France
4Institut d'Hématologie, CHU de Caen, Caen, France
5Nancy University Hospital, Vandoeuvre Les Nancy, FRA
6Centre Hospitalier Lyon Sud, Lyon, France
7Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
8Hematology Department, CHU de Poitiers, Poitiers, France
9Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
10Hematology department, Centre Hospitalier Universitaire, Lille, France
11Hematology clinic, Nantes University Hospital, Nantes, France
12Nantes University Hospital, Nantes, FRA

Kimimori Kamijo1*, Yoshimitsu Shimomura2*, Takayoshi Tachibana, MD, PhD3*, Yuho Najima, MD, PhD4, Jun Aoki, MD, PhD5*, Yu Akahoshi, MD, PhD6*, Masatsugu Tanaka, M.D., Ph.D.3*, Noriko Doki, MD, PhD7, Naoyuki Uchida, MD, PhD8, Hiroyuki Ohigashi, MD, PhD9*, Hikaru Kobayashi10*, Shuichi Ota, MD11, Miho Nara12*, Shinichiro Fujiwara, MD, PhD13*, Yasuo Mori, M.D., Ph.D.14,15*, Yoshinobu Kanda16*, Tatsuo Ichinohe17*, Yoshiko Atsuta, MD, PhD18* and Yasuyuki Arai, MD, PhD19,20

1Department of Hematology, Rinku General Medical Center, Izumisanoshi, HYO, Japan
2Department of Hematology, Kobe City Hospital Organization, Kobe, Japan
3Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
4Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, TKY, Japan
5Department of Hematology, Kanto Rosai Hospital, Kawasaki, Japan
6Icahn School of Medicine at Mount Sinai, New York, NY
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematology, Toranomon Hospital, Tokyo, Japan
9Department of Hematology, Hokkaido University Hospital, Sapporo, HOK, JPN
10Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan
11Sapporo Hokuyu Hospital, Sapporo, JPN
12Center for Transfusion Cell Therapy, Transplantation and Regenerative Medicine, Akita University Hospital, Akita, JPN
13Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan
14Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
15Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, JPN
16Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
17Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
18Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan
19Kyoto University, Kyoto, JPN
20Department of Hematology, Kyoto University Hospital, Kyoto, Japan

Amandeep Salhotra, MD1, Monzr M. Al Malki, MD1, Dongyun Yang, PhD2*, Sally Mokhtari, PhD3, Ibrahim Aldoss, MD4, Ahmed Aribi, MD4*, Idoroenyi Amanam, MD5, Haris Ali, MD4, Karamjeet S. Sandhu, MD4, Vaibhav Agrawal, M.D.4, Paul B. Koller, MD4, Brian J. Ball, MD4, Shukaib Arslan, MD4, Salman Otoukesh, MD4, Amanda Blackmon, DO, MS4*, Hoda Pourhassan, MD6, Yazeed Samara, MD4,5*, Tamer Othman, MD7, Pamela S. Becker, MD, PhD4, Vinod Pullarkat, MD4, Ricardo Spielberger, MD4, Forest Marc Stewart, MD4, Eileen Patricia Smith, MD4, Andrew Artz, MD, MS8, Stephen J. Forman, MD, FACP4, Guido Marcucci, MD4, Anthony Stein, MD4 and Ryotaro Nakamura, MD9

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Clinical and Translational Project Development, City of Hope National Medical Center, Duarte
4Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5City of Hope National Medical Center, Duarte, CA
6Hematology/HCT, City of Hope, Duarte, CA
7City of Hope, San Lorenzo, CA
8City of Hope, Duarte, CA
9Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA

Ayman Sayyed, BMBS, MRCP1*, Taehyung Simon Kim2*, Silvia Park3*, Jae-Sook Ahn4*, Aly Karsan, MD5, Marie-France Gagnon, MD6*, Julie Bergeron, MD6, Hyeoung-Joon Kim4, Heeje Kim, MD, PhD7, David Sanford, MD, FRCPC8, Andre C. Schuh, MD, FRCPC2 and Dennis Dong Hwan Kim, MD, PhD2

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Riyadh, Saudi Arabia
2Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
4Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
5BC Cancer Research Institute, University of British Columbia, Vancouver, BC, CAN
6CEMTL, installation Maisonneuve-Rosemont, Montreal, QC, Canada
7Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
8Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Vancouver, Canada

Rohan Halder, MD, MBBS1*, Reshmi Harikumar Pillai1*, Vinayak Hemant Gupta1*, Sujay Rainchwar, MD, DrNB1*, Karuna Jha, MD1*, Tribikram Panda, MD1*, Rayaz Ahmed, MD2, Narendra Agrawal, MD, DM1*, Reema Singh, M.Sc.1* and Dinesh Bhurani, MD, DM, FRCPA1*

1HEMATOLOGY, RAJIV GANDHI CANCER INSTITUTE & RESEARCH CENTRE, NEW DELHI, India
2HEMATOLOGY, MAX SUPERSPECIALITY HOSPITAL, DELHI, India

*signifies non-member of ASH